STEPHAN DIETRICH A (President and CEO) exercised options at NEUBASE THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/5/2022ACC: 0001104659-22-001691
DirectorOfficer· President and CEO
Since Jul 2019
0.00
Net shares
Net seller
$42.25
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
42.25K acquired · 42.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+42.25K
Price / share
$0.00
Trade value
$42.25
% of position
172.3%
12/31/2021
24.52K→66.78K
Total
Net shares
+42.25K
Net value
$42.25
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2021 | M · Option Exercise | +42.25K | $0.00 | $42.25 | 172.3% | 24.52K | 66.78K |
| Total | +42.25K | $42.25 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
42.25K shares
Shares
−42.25K
Strike price
0.001
Held after
3.27M
Exercisable
—
12/31/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock42.25K shares | 12/31/2021 | M · Option Exercise | −42.25K | 0.001 | — | 3.27M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.27M
Total
1.27M indirect1.27M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.27M | Indirect |
| Total | 1.27M | 1.27M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported